| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3991124 | Journal of Thoracic Oncology | 2011 | 7 Pages |
Abstract
Preoperative celecoxib with concurrent chemotherapy demonstrated sufficient effect on pathologic response to warrant further study. Patients with tumors expressing COX-2 demonstrated trends toward improved response to preoperative therapy and improved overall survival compared with nonexpressors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nasser K. MD, Paul DrPH, Jeff L. MD, Paul C. MD, Farooq MD, Cathy RN, Roger MD, Debra MD, Subroto MD, Brendon M. MD, Yuwei MD, David S. MD, MBA,